| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.41B | 10.76B | 9.06B | 15.01B | 17.32B | 13.48B |
| Gross Profit | 3.76B | 2.35B | 1.61B | 5.14B | 8.57B | 5.08B |
| EBITDA | 4.88B | 3.67B | 1.92B | 5.97B | 8.44B | 6.37B |
| Net Income | 1.85B | 1.40B | 406.00M | 2.41B | 3.32B | 2.87B |
Balance Sheet | ||||||
| Total Assets | 46.64B | 45.44B | 47.04B | 56.19B | 52.36B | 47.37B |
| Cash, Cash Equivalents and Short-Term Investments | 5.43B | 5.01B | 7.59B | 744.00M | 1.88B | 1.43B |
| Total Debt | 9.77B | 9.61B | 9.96B | 11.09B | 10.02B | 9.33B |
| Total Liabilities | 19.43B | 19.43B | 19.94B | 27.90B | 25.85B | 23.59B |
| Stockholders Equity | 26.27B | 25.10B | 26.08B | 26.99B | 25.47B | 23.00B |
Cash Flow | ||||||
| Free Cash Flow | 482.00M | -1.02B | 155.00M | -1.70B | 2.52B | 25.00M |
| Operating Cash Flow | 2.78B | 1.04B | 2.79B | 4.08B | 7.98B | 4.74B |
| Investing Cash Flow | -2.17B | -2.00B | 6.17B | -4.76B | -5.68B | -4.82B |
| Financing Cash Flow | -1.21B | -1.32B | -2.56B | -469.00M | -1.99B | 1.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | C$41.11B | 10.71 | 7.35% | 0.78% | 5.10% | 429.79% | |
73 Outperform | C$1.84B | 2.33 | 39.07% | 9.17% | 36.51% | 80.51% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
49 Neutral | C$16.06B | 182,231.70 | 2.32% | ― | 336.94% | -70.03% | |
47 Neutral | C$2.29B | -872.55 | -12.78% | ― | ― | -161.83% | |
46 Neutral | C$6.80B | -267.64 | -59.18% | ― | 72.91% | -172.72% | |
46 Neutral | C$4.91B | -12.06 | -185.40% | ― | ― | -32.52% |